Lifevantage ROA 2012-2026 | LFVN
Current and historical return on assets (ROA) values for Lifevantage (LFVN) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Lifevantage ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2026-03-31 | $0.01B | $0.06B | 7.78% |
| 2025-12-31 | $0.01B | $0.07B | 10.29% |
| 2025-09-30 | $0.01B | $0.07B | 14.29% |
| 2025-06-30 | $0.01B | $0.07B | 14.34% |
| 2025-03-31 | $0.01B | $0.07B | 13.48% |
| 2024-12-31 | $0.01B | $0.06B | 12.75% |
| 2024-09-30 | $0.00B | $0.06B | 6.53% |
| 2024-06-30 | $0.00B | $0.06B | 4.78% |
| 2024-03-31 | $0.00B | $0.06B | 6.23% |
| 2023-12-31 | $0.00B | $0.07B | 4.56% |
| 2023-09-30 | $0.00B | $0.07B | 4.48% |
| 2023-06-30 | $0.00B | $0.07B | 4.46% |
| 2023-03-31 | $0.00B | $0.07B | 0.00% |
| 2022-12-31 | $0.00B | $0.07B | 0.00% |
| 2022-09-30 | $0.00B | $0.07B | 1.41% |
| 2022-06-30 | $0.00B | $0.07B | 4.12% |
| 2022-03-31 | $0.01B | $0.08B | 12.04% |
| 2021-12-31 | $0.01B | $0.08B | 13.25% |
| 2021-09-30 | $0.01B | $0.08B | 18.42% |
| 2021-06-30 | $0.01B | $0.08B | 17.45% |
| 2021-03-31 | $0.01B | $0.07B | 17.27% |
| 2020-12-31 | $0.01B | $0.06B | 18.82% |
| 2020-09-30 | $0.01B | $0.06B | 20.34% |
| 2020-06-30 | $0.01B | $0.06B | 21.62% |
| 2020-03-31 | $0.01B | $0.06B | 22.02% |
| 2019-12-31 | $0.01B | $0.06B | 21.82% |
| 2019-09-30 | $0.01B | $0.06B | 16.44% |
| 2019-06-30 | $0.01B | $0.05B | 14.88% |
| 2019-03-31 | $0.01B | $0.05B | 13.27% |
| 2018-12-31 | $0.01B | $0.05B | 13.46% |
| 2018-09-30 | $0.01B | $0.05B | 12.00% |
| 2018-06-30 | $0.01B | $0.05B | 12.44% |
| 2018-03-31 | $0.00B | $0.05B | 6.42% |
| 2017-12-31 | $0.00B | $0.05B | 2.19% |
| 2017-09-30 | $0.00B | $0.05B | 2.17% |
| 2017-06-30 | $0.00B | $0.05B | 2.12% |
| 2017-03-31 | $0.00B | $0.05B | 6.15% |
| 2016-12-31 | $0.00B | $0.05B | 8.33% |
| 2016-09-30 | $0.01B | $0.05B | 12.63% |
| 2016-06-30 | $0.01B | $0.05B | 13.33% |
| 2016-03-31 | $0.00B | $0.04B | 9.47% |
| 2015-12-31 | $0.00B | $0.04B | 9.30% |
| 2015-09-30 | $0.00B | $0.05B | 6.74% |
| 2015-06-30 | $0.01B | $0.05B | 14.36% |
| 2015-03-31 | $0.01B | $0.05B | 17.22% |
| 2014-12-31 | $0.01B | $0.06B | 17.24% |
| 2014-09-30 | $0.01B | $0.06B | 19.67% |
| 2014-06-30 | $0.01B | $0.06B | 16.60% |
| 2014-03-31 | $0.01B | $0.06B | 13.22% |
| 2013-12-31 | $0.01B | $0.06B | 15.93% |
| 2013-09-30 | $0.01B | $0.06B | 11.01% |
| 2013-06-30 | $0.01B | $0.05B | 13.08% |
| 2013-03-31 | $0.01B | $0.05B | 23.53% |
| 2012-12-31 | $0.00B | $0.05B | 8.74% |
| 2012-09-30 | $0.01B | $0.04B | 33.99% |
| 2012-06-30 | $0.01B | $0.03B | 43.33% |
| 2012-03-31 | $-0.04B | $0.02B | -179.31% |
| 2011-12-31 | $-0.04B | $0.02B | -275.00% |
| 2011-09-30 | $-0.05B | $0.01B | -417.39% |
| 2011-06-30 | $-0.05B | $0.01B | -566.67% |
| 2011-03-31 | $-0.01B | $0.01B | -120.00% |
| 2010-12-31 | $-0.01B | $0.01B | -107.69% |
| 2010-09-30 | $-0.01B | $0.01B | -216.67% |
| 2010-06-30 | $-0.01B | $0.01B | -236.36% |
| 2010-03-31 | $-0.01B | $0.01B | -236.36% |
| 2009-12-31 | $-0.01B | $0.01B | -145.45% |
| 2009-09-30 | $-0.01B | $0.01B | -152.38% |
| 2009-06-30 | $-0.01B | $0.01B | -180.00% |
| 2009-03-31 | $-0.01B | $0.01B | -105.26% |
| 2008-12-31 | $0.00B | $0.01B | -66.67% |
| 2008-09-30 | $0.00B | $0.01B | -42.11% |
| 2008-06-30 | $0.00B | $0.01B | -40.00% |
| 2008-03-31 | $0.00B | $0.01B | -42.11% |
| 2007-12-31 | $0.00B | $0.01B | -42.11% |
| 2007-09-30 | $0.00B | $0.01B | -80.00% |
| 2007-06-30 | $-0.01B | $0.01B | -90.91% |
| 2007-03-31 | $-0.01B | $0.01B | -85.71% |
| 2006-12-31 | $-0.01B | $0.01B | -68.57% |
| 2006-09-30 | $-0.01B | $0.01B | -48.78% |
| 2006-06-30 | $0.00B | $0.01B | -34.04% |
| 2006-03-31 | $0.00B | $0.01B | 32.65% |
| 2005-12-31 | $-0.01B | $0.01B | -60.00% |
| 2005-09-30 | $-0.01B | $0.01B | -85.71% |
| 2005-06-30 | $-0.01B | $0.00B | -160.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.053B | $0.229B |
| Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |